KEGG pathway analysis of the 43 commonly inhibited MRs further indicated enrichment of proteins involved in EGFR tyrosine kinase inhibitor resistance, hinting that the therapeutic response of GBM cells against EGFR-targeting compounds may be attenuated in the absence of EMP3 (Fig. 5D). Here, EMP3 is linked to glioblastoma.